The Wall Street Journal looks at a growing number of teen boys using peptides, supplements and online advice as they try to improve themselves.
Recap by typeshit. Post by Facebook on Facebook.
A local TV health segment on safety when using peptide therapy and GLP-1 drugs, aimed at men's health.
A Williamsburg shop sells injectable peptide vials for around $95 each, while the FDA has sent warning letters to sellers relying on the same label.
9:07
The endocrinologist takes on whether people can get retatrutide now, setting gray market supply against the results from Lilly's actual trials.
UW Medicine notes that many of these experimental peptides have not been regulated by the FDA, and some have never been tested in people.
More teen boys are trying peptides, supplements and online advice to improve themselves. The Wall Street Journal looks at what is driving the trend.
Lilly reports all three doses met their goals at 80 weeks, with about 11% quitting on 12 mg and 13% reporting dysesthesia. Shares rose about 1% premarket.
Loading…